A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

Clinical trial NCT07005154 · RECRUITING

Trial details

NCT number: NCT07005154
Sponsor: Astellas Pharma Global Development, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Metastatic Castration-Resistant Prostate Cancer Metastatic Hormone Sensitive Prostate Cancer

Start date: 2025-06-19
Primary completion: 2032-05-31
Enrollment: 218

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.